一例因後續感染巨細胞病毒導致難治性的血栓性血小板減少性紫斑症－病例報告

A Case of Refractory Thrombotic Thrombocytopenic Purpura Due to Subsequent Infection with CMV: A Case Report

10.3966/168232812020093003005

楊佩玉(Pei-Yu Yang)；鄭雅綺(Ya-Chi Cheng)；翁千惠(Chien-Hui Weng)；楊玉英(Yu-Ying Yang)；林益卿(I-Ching Lin)；張舜智(Hsun-Chin Chang)

血栓性血小板減少性紫斑症 ； vWF解離酶 ； 治療性血漿置換 ； 巨細胞病毒 ； A disintegrin and metalloproteinase with thrombospondin motifs ； 13 (ADAMST13) ； cytomegalovirus (CMV) ； therapeutic plasma exchange (TPE) ； thrombotic thrombocytopenic purpura (TTP)

台灣家庭醫學雜誌

30卷3期（2020 / 09 / 01）

169 - 176

繁體中文

一名55歲男性，因身心疾病長期在療養院住院，因護理人員發現全身多處紫斑而至地區醫院求診，實驗室報告顯示嚴重的血小板減少，醫師懷疑可能為血栓性血小板減少性紫斑症（thrombotic thrombocytopenic purpura, TTP），轉至醫學中心就診。經ADAMTS13活性分析確診為TTP，以血漿置換（therapeutic plasma exchange, TPE）治療。因病人家屬要求，轉至本院就診，入院之初以血漿置換和類固醇治療，幾天後血小板明顯上升，但三週後儘管每天仍進行血漿置換和類固醇治療，病人血小板計數仍持續下降。後續因檢測到巨細胞病毒（CMV）的感染，經抗病毒劑治療後，血小板回升。CMV引起的TTP在文獻上並不多見，在臨床上若治療TTP未達到預期的改善時，可能須考慮是否為CMV感染。

A 55-year-old schizophrenic male nursing home resident was found multiple purpura throughout the body and sent to a regional hospital for treatment.Laboratory data showed severe thrombocytopenia, and TTP was suspected; the patient was then referred to a medical center. TTP was diagnosed by ADAMTS13 activity analysis and treated with plasma exchange. Upon to the request of the patient's family, he was transferred to our hospital for treatment. At the beginning, he was still treated with plasma exchange and steroid. After three weeks of continuous daily plasma exchange and high-dose steroid, his platelet count remained low.During the treatment, an infection with CMV was detected, and platelets recovered after treatment with antiviral agents. CMV-induced TTP is rare in the literature. If the treatment of TTP fails to achieve expected improvement, it may be necessary to consider whether it is a CMV infection.

1. Barrows, BD,Teruya, J(2014).Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura.Arch Pathol Lab Med,138,546-549.
2. Bianchi, V,Robles, R,Alberio, L,Furlan, M,Lämmle, B(2002).Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.Blood,100,710-713.
3. Boteju, M,Weeratunga, P,Sivashangar, A,Chang, T(2019).Cytomegalovirus induced refractory TTP in an immunocompetent individual: a case report.BMC Infect Dis,19,394.
4. Chiasakul, T,Cuker, A(2018).Clinical and laboratory diagnosis of TTP: an integrated approach.Hematology Am Soc Hematol Educ Program,2018,530-538.
5. Cserti, CM,Landaw, S,Uhl, L(2007).Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?.J Clin Apher,22,21-25.
6. Furlan, M,Lammle, B(1998).Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.Baillieres Clin Haematol,11,509-514.
7. Furlan, M,Robles, R,Solenthaler, M,Lämmle, B(1998).Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.Blood,91,2839-2846.
8. Furlan, M,Robles, R,Solenthaler, M,Wassmer, M,Sandoz, P,Lämmle, B(1997).Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.Blood,89,3097-3103.
9. George MD, Cuker MD. Acquired TTP: Treatment of refractory or relapsed disease. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com
10. Kawasaki, Y,Toyoda, H,Otsuki, S(2013).A novel Wiskott-Aldrich syndrome protein mutation in an infant with thrombotic thrombocytopenic purpura.Eur J Haematol,90,164-168.
11. Lammle, B,Kremer Hovinga, JA,Alberio, L(2005).Thrombotic thrombocytopenic purpura.J Thromb Haemost,3,1663-1675.
12. Lopes da Silva, R(2011).Viral-associated thrombotic microangiopathies.Hematol Oncol Stem Cell Ther,4,51-59.
13. Moake, JL,Rudy, CK,Troll, JH(1982).Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.N Engl J Med,307,1432-1435.
14. Rieger, M,Ferrari, S,Kremer Hovinga, JA(2006).Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA).Thromb Haemost,95,212-220.
15. Yamazaki, M,Takei, T,Otsubo, S(2007).Wegener’s granulomatosis complicated by intestinal ulcer due to cytomegalovirus infection and by thrombotic thrombocytopenic purpura.Intern Med,46,1435-1440.
16. Zander, CB,Cao, W,Zheng, XL(2015).ADAMTS13 and von Willebrand factor interactions.Curr Opin Hematol,22,452-459.
17. Zheng, XL(2015).ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.Annu Rev Med,66,211-225.